Annual FCF
-$12.75 M
+$7.76 M+37.84%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual free cash flow is -$12.75 million, with the most recent change of +$7.76 million (+37.84%) on December 31, 2023.
- During the last 3 years, VVOS annual FCF has fallen by -$6.95 million (-119.81%).
- VVOS annual FCF is now -131.12% below its all-time high of -$5.52 million, reached on December 31, 2019.
Performance
VVOS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$4.38 M
-$1.27 M-40.89%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly free cash flow is -$4.38 million, with the most recent change of -$1.27 million (-40.89%) on September 30, 2024.
- Over the past year, VVOS quarterly FCF has stayed the same.
- VVOS quarterly FCF is now -890.50% below its all-time high of -$442.10 thousand, reached on March 1, 2020.
Performance
VVOS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$13.07 M
-$1.43 M-12.24%
September 30, 2024
Summary
- As of February 8, 2025, VVOS TTM free cash flow is -$13.07 million, with the most recent change of -$1.43 million (-12.24%) on September 30, 2024.
- Over the past year, VVOS TTM FCF has stayed the same.
- VVOS TTM FCF is now -2855.67% below its all-time high of -$442.10 thousand, reached on March 1, 2020.
Performance
VVOS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VVOS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.8% | 0.0% | 0.0% |
| 3 y3 years | -119.8% | +2.7% | +24.6% |
| 5 y5 years | -94.2% | -6.2% | -37.8% |
VVOS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.8% | -64.2% | +29.4% | -12.3% | +40.1% |
| 5 y | 5-year | -131.1% | +37.8% | -890.5% | +29.4% | -2855.7% | +40.1% |
| alltime | all time | -131.1% | +37.8% | -890.5% | +29.4% | -2855.7% | +40.1% |
Vivos Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.38 M(+40.9%) | -$13.07 M(+12.2%) |
| Jun 2024 | - | -$3.11 M(+16.5%) | -$11.64 M(+0.0%) |
| Mar 2024 | - | -$2.67 M(-8.4%) | -$11.64 M(-8.7%) |
| Dec 2023 | -$12.75 M(-37.8%) | -$2.91 M(-1.4%) | -$12.75 M(-2.2%) |
| Sep 2023 | - | -$2.95 M(-4.8%) | -$13.04 M(-18.6%) |
| Jun 2023 | - | -$3.10 M(-17.8%) | -$16.02 M(-11.4%) |
| Mar 2023 | - | -$3.78 M(+18.1%) | -$18.09 M(-11.8%) |
| Dec 2022 | -$20.51 M | -$3.20 M(-46.1%) | -$20.51 M(-6.0%) |
| Sep 2022 | - | -$5.94 M(+15.0%) | -$21.82 M(+7.1%) |
| Jun 2022 | - | -$5.17 M(-16.7%) | -$20.37 M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.20 M(+37.7%) | -$20.21 M(+11.5%) |
| Dec 2021 | -$18.13 M(+212.6%) | -$4.50 M(+0.1%) | -$18.13 M(+4.6%) |
| Sep 2021 | - | -$4.50 M(-10.1%) | -$17.34 M(+28.2%) |
| Jun 2021 | - | -$5.00 M(+21.4%) | -$13.53 M(+42.7%) |
| Mar 2021 | - | -$4.12 M(+11.0%) | -$9.48 M(+63.5%) |
| Dec 2020 | -$5.80 M(+5.1%) | -$3.71 M(+440.9%) | -$5.80 M(+177.9%) |
| Sep 2020 | - | -$686.40 K(-28.4%) | -$2.09 M(+49.0%) |
| Jun 2020 | - | -$958.40 K(+116.8%) | -$1.40 M(+216.8%) |
| Mar 2020 | - | -$442.10 K | -$442.10 K |
| Dec 2019 | -$5.52 M(-16.0%) | - | - |
| Dec 2018 | -$6.56 M | - | - |
FAQ
- What is Vivos Therapeutics annual free cash flow?
- What is the all time high annual FCF for Vivos Therapeutics?
- What is Vivos Therapeutics annual FCF year-on-year change?
- What is Vivos Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly FCF year-on-year change?
- What is Vivos Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Vivos Therapeutics?
- What is Vivos Therapeutics TTM FCF year-on-year change?
What is Vivos Therapeutics annual free cash flow?
The current annual FCF of VVOS is -$12.75 M
What is the all time high annual FCF for Vivos Therapeutics?
Vivos Therapeutics all-time high annual free cash flow is -$5.52 M
What is Vivos Therapeutics annual FCF year-on-year change?
Over the past year, VVOS annual free cash flow has changed by +$7.76 M (+37.84%)
What is Vivos Therapeutics quarterly free cash flow?
The current quarterly FCF of VVOS is -$4.38 M
What is the all time high quarterly FCF for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly free cash flow is -$442.10 K
What is Vivos Therapeutics quarterly FCF year-on-year change?
Over the past year, VVOS quarterly free cash flow has changed by $0.00 (0.00%)
What is Vivos Therapeutics TTM free cash flow?
The current TTM FCF of VVOS is -$13.07 M
What is the all time high TTM FCF for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM free cash flow is -$442.10 K
What is Vivos Therapeutics TTM FCF year-on-year change?
Over the past year, VVOS TTM free cash flow has changed by $0.00 (0.00%)